Revenue from Contracts with Customers (Tables)

12 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Year ended September 30,
	2021			2020	2019
Significant Business Line
Brooks Life Sciences Products	$	199,606	$	129,759	$	119,020
Sample Repository Solutions		93,429		92,332		88,896
Genomic Services		220,668		166,446		126,263
Total	$	513,703	$	388,537	$	334,179

Remaining Performance Obligations

	As of September 30, 2021
	Less than 1 Year		Greater than 1 Year		Total
Remaining Performance Obligations	$	33,552	$	16,915	$	50,467